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Background/purpose:  The  purpose  of  this  study  is  to  characterize  GBS  isolates  that
were  collected  from  three  major  hospitals  in  a  densely  populated  area  of  Klang  Val-
ley  for  their  demographics,  serotypes,  antibiotic  susceptibility  patterns  and  genetic
background.
Methods:  Sixty  GBS  isolates  from  sterile  and  non-sterile  samples  in  three  major
hospitals  in  the  Klang  Valley  area  of  Malaysia  were  collected  by  convenience  sampling
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from  2012  until  March  2014.  These  isolates  were  studied  for  their  antimicrobial
susceptibilities,  serotypes  and  genotypes.  Patients’  demographic  data  and  clinical
information  were  collected  from  lab  request  forms.
Results:  Diabetes  mellitus  was  the  only  underlying  condition  (7  patients,  23.3%);  the
remaining  samples  were  from  patients  who  were  immunocompromised  due  to  medi-
cations.  Fifty-nine  (98%)  isolates  were  sensitive  to  penicillin,  while  78.3%  and  88.3%  of
the  isolates  were  sensitive  to  erythromycin  and  clindamycin,  respectively.  Serotype  Ia
was  the  most  common  serotype  (n  =  27,  45%),  followed  by  serotype  III  (n  =  10,  16.7%),  V
(n  =  9,  15%),  VI  (n  =  8,  13.3%),  VIII  (n  =  2,  3.3%)  and  VII  (n  =  1,  1.7%).  Random  Ampliﬁed
Polymorphic  DNA  (RAPD)  typing  showed  a  diverse  genetic  pedigree  for  all  isolates,
including  four  major  groups  that  clustered  according  to  geographical  location.
Conclusion:  This  preliminary  study  determines  the  prevalence  of  limited  common
serotypes  and  antimicrobial  resistance  in  distinct  GBS  isolates.  Nonetheless,  the  RAPD
clustering  pattern  suggests  a  close  genetic  lineage  of  the  GBS  isolates  based  on  their
isolation  sites  and  location  of  hospitals.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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reviewed information  on  demographic  data,  site  of
isolation, associated  underlying  conditions  and  clin-
ical presentation.  All  isolates  were  identiﬁed  by©  2016  King  Saud  Bin  Ab
Limited.  All  rights  reserv
ntroduction
roup  B  Streptococcus  (GBS),  also  known  as  Strep-
ococcus  agalactiae, is  a  frequent  colonizer  of  the
agina in  pregnant  women,  as  well  as  the  gastroin-
estinal and  genitourinary  tract  in  healthy  adults
1].  GBS  can  cause  a  variety  of  severe  diseases,  such
s sepsis,  pneumonia  and  meningitis,  in  neonates.  It
lso promotes  serious  mortality  in  immunocompro-
ised patients  and  morbidity  in  pregnant  women
nd non-pregnant  adults  [2,3]. The  Centers  for
isease Control  and  Prevention  (CDC)  published
uidelines for  intrapartum  antibiotic  prophylaxis
n 1996  and  recommended  penicillin  or  ampi-
illin as  the  drugs  of  choice  for  the  prevention
f perinatal  GBS  disease  [4], while  erythromycin
nd clindamycin  may  serve  as  alternative  antibi-
tics for  women  who  are  allergic  to  penicillin
5].  An  important  factor  that  contributes  to  GBS
athogenicity  is  capsular  polysaccharide  (cps).  Gen-
rally, nine  serotypes  (Ia,  Ib  and  II  to  VIII)  have  been
ecognized,  and  most  recently,  serotype  IX  was  pro-
osed [6].  Epidemiologically,  serotype  Ia,  III  and
 are  commonly  associated  with  invasive  disease
n pregnant  women,  neonates  and  non-pregnant
dults. However,  there  may  be  geographical  and
emporal  variations  in  the  prevalence  pattern  of
he serotypes  [7]. To  the  best  of  our  knowledge,
ublished  reports  on  GBS  cases  in  Malaysia  are  still
imited.  Therefore,  the  purpose  of  this  study  was
o characterize  GBS  isolates  collected  from  a few
ajor hospitals  in  Malaysia  for  their  demograph-
cs, serotypes,  antibiotic  susceptibility  patterns  and
s
l
senetic  background.  Comparative  analysis  was  con-
ucted to  reveal  potential  epidemiological  patterns
f local  GBS  isolates.
ethods
acterial isolates and patients’ clinical
nformation
his  study  included  60  GBS  isolates  collected  from
terile and  non-sterile  sites  of  patients  at  three
ajor hospitals  located  in  the  densely  populated
rea of  Klang  Valley;  Hospital  Serdang  and  Univer-
iti Kebangsaan  Malaysia  Medical  Centre  (UKMMC),
hich are  the  teaching  and  referral  hospitals  in
alaysia,  and  Hospital  Kuala  Lumpur  (HKL),  which
s the  largest  government  tertiary  referral  hospital
ocated  on  150  acres  of  prime  land  in  the  Federal
erritory  of  Kuala  Lumpur  with  83  wards  and  2302
eds. The  samples  were  collected  at  convenience
o include  viable  isolates  with  available  patients’
nformation from  2012  until  2014;  10  isolates  each
rom sterile  and  non-sterile  sites  were  randomly
argeted from  each  hospital.  Of  the  60  GBS  iso-
ates, 28  cases  were  in  the  year  2013,  21  cases
n 2014  and  11  cases  in 2012.  The  present  studytandard  laboratory  methods  and  kept  at  −70 ◦C  for
ong-term  preservation  and  at  4 ◦C  for  short-term
torage.
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Antimicrobial susceptibility testing
Antimicrobial  susceptibility  testing  (AST)  was  per-
formed by  disc  diffusion  (Kirby—Bauer)  method
according to  CLSI  guidelines  [8]. The  panel
of antibiotics  included  a  beta-lactam  (peni-
cillin), a  macrolide  (erythromycin),  a lincosamide
(clindamycin),  a  phenicol  (chloramphenicol)  and
tetracycline.  Etest® strip  (Lioﬁlchem®Rosetodegli
Abruzzi (Te),  Italy)  was  utilized  with  GBS  isolates
to determine  the  Minimal  Inhibitory  Concentration
(MIC) of  isolates  that  had  high  or  intermediate  resis-
tance to  penicillin,  erythromycin  and  clindamycin
based on  the  disc  diffusion  test.  Streptococcus
pneumoniae  ATCC  49619  was  used  for  quality  con-
trol. Double  disc  diffusion  (D  test)  was  also  applied
to check  for  inducible  clindamycin  resistance  in  GBS
isolates resistant  to  erythromycin  but  susceptible  to
clindamycin.
Serotyping
Ten  serotype  (Ia,  Ib  and  II  to  IX)  reagents  were
tested against  GBS  isolates  by  conventional  serotyp-
ing (CS)  via  Latex  Agglutination  Kit  (Statens  Serum
Institute,  SSI,  Sweden).  Isolates  that  failed  to  form
any agglutination  with  any  serotype  reagents  were
labeled  as  non-typeable  (NT).  Molecular  serotyping
(MS) by  multiplex  PCR  was  also  performed  on  all  iso-
lates using  a  series  of  primers  according  to  Imperi
et al.  [9].  DNA  was  extracted  using  GeneAll  Exgene
Cell SV  Mini  genomic  extraction  kit  (GeneAll,  South
Korea)  according  to  the  manufacturer’s  instruc-
tions.RAPD-based genotyping
DNA  from  GBS  isolates  was  subjected  to  Random
Ampliﬁed Polymorphic  DNA  (RAPD)  assay  reaction  to
G
8
9
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Table  1  Distribution  of  the  GBS  isolates  in  relation  to  the  
Age  (y)  Isolation  sitea Sex  
Sterile
(n  =  30)
Non-sterile
(n =  30)
Male
(n  =  22)
Fe
(n
0—10  (n  =  6)  6  0  4  2
11—20  (n  =  0)  0  0  0  0
21—30  (n  =  16)  1  15  0  16
31—40  (n  =  12)  3  9  3  9
41—50  (n  =  7)  5  2  4  3
51—60  (n  =  11)  7  4  5  6
61—70  (n  =  4)  4  0  4  0
71—80  (n  =  4) 4 0  2  2
y = 10 year interval.
a Sterile site: Blood, Tissue; Non-sterile site: High vaginal swab, M.E.S.  Suhaimi  et  al.
etermine  the  genetic  backgrounds  of  the  isolates.
olymerase  chain  reaction  (PCR)  cycling  conditions
ere applied  as  described  by  Duremdez  et  al.  [10]
ith  P2  [10]  and  GBS-2  primers  [11]  using  a  DNA
hermocycler  (Biometra-TRIO  Thermoblock).  DNA
lectrophoretic  patterns  were  analyzed  using  BioN-
merics  gel  analysis  software  Version  7.0  (Applied
aths,  Belgium)  on  the  basis  of the  presence  or
bsence  of  DNA  bands.  RAPD  dendrograms  based
n each  and  a  composite  of  all  primers  were  then
enerated by  the  software  using  the  average  coef-
cient UPGMA  cluster  analysis.
tatistical analysis
hi-Square  test  of  independence  was  used  to
nalyze the  tabulations  among  the  serotype,
ntimicrobial patterns,  hospital  source  of  isola-
ion and  genotypic  properties  using  GraphPad  Prism
oftware Version  5 (GraphPad  Software,  USA)  with
 <  0.05  as  the  signiﬁcance  level.
esults
istribution of bacterial isolates
able  1  shows  the  tabulation  of  the  GBS  isolates  in
elation to  patient  demographic  and  isolation  sites.
f the  sixty  GBS-associated  patients,  there  were
2 (36.7%)  males  and  38  (63.3%)  females.  A  major-
ty was  in  the  21—40-year-old  age  group  (n  =  28,
6.7%),  followed  by  the  41—60-year-old  (n  =  18,
0%) and  61—80-year-old  age  group  (n  =  8,  13.3%).
n the  21—40-year-old  age  group,  the  majority  of
BS were  isolated  from  non-sterile  sites  (n  =  24,
5.7%), which  comprised  high  vaginal  swab  (n  =  22,
2%) and  placenta  swab  (n  =  2,  8%),  while  those  in
he 41—80-year-old  age  group  were  isolated  from
age,  isolation  site,  sex  and  ethnicity  of  patients.
Ethnicity
male
 =  38)
Malay
(n =  49)
Chinese
(n =  2)
Indian
(n =  7)
Punjabi
(n =  2)
 6  0  0  0
 0  0  0  0
 15  1  0  0
 11  0  1  0
 5  0  2  0
 4  1  4  2
 4  0  0  0
 4  0  0  0
Urine, Placenta swab.
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Table  2
CS  based-serotype  MS-based  serotype  Total  (CS)
Ia  Ib  II  III  IV  V  VI  VII  VIII  IX
Ia  15  15
Ib  0  0
II  3  3
III  7  7
IV  0  0
V  6  6
VI  5  5
VII  1  1
VIII  1  1
IX  0  0
NT  12  0  0  3  0  3  3  0  1  0  22a
Total  (MS)  27  0  3  10  0  9  8  1  2  0  60
CS, conventional serotyping (latex); MS, molecular serotyping (multiplex PCR).
MS.
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association  was  found  between  the  erythromycin-
and clindamycin-resistant  isolates  in  relation  to  iso-
lation sites,  ethnicity  and  age  of  patients  (p  >  0.05).
Serotyping
Among  the  60  isolates,  38  isolates  (63.3%)  were  suc-
cessfully  serotyped  using  a latex  agglutination  kit,
while 22  isolates  (36.7%)  were  non-typeable  (NT).
Nevertheless,  the  later  NT  isolates  were  success-
fully typed  by  MS.  Furthermore,  MS  also  gave  results
consistent  with  the  earlier  serological  data  on  the
38 isolates.  Taking  CS  and  MS  together,  the  most
common  serotype  in  this  study  was  Ia  (n  = 27,  45%),
followed  by  III  (n  =  10,  16.7%),  V  (n  =  9,  15%),  VI
(n = 8,  13.3%),  VIII  (n  = 2,  3.3%)  and  VII  (n  =  1,  1.7%).
Serotype Ib,  IV  and  IX  were  not  found  in  the  present
study. (Table  2).
The  distribution  of  various  serotypes  accord-
ing to  resistance  isolates  is  shown  in  Table  3.
Only serotype  Ia,  III  and  V  isolates  were  found  to
be resistant  to  erythromycin  and  clindamycin.  Of
these three  serotypes,  only  serotype  III  was  signif-
icantly  distributed  among  the  isolates  resistant  to
Table  3  Distribution  of  serotypes  Ia,  III  and  V  in  rela-
tion  to  erythromycin  and  clindamycin  resistance  of  the
GBS  isolates.
Serotype  Erythromycin  n  =  13  Clindamycin  n  =  7
Ia  (n  =  6)  5  (38)  1  (14)
III  (n  =  9)  5  (38)* 4  (57)*NT — non-typeable serotype.
a All 22 NT isolates based on CS were successfully typed by 
terile  sites  (n  =  20,  76.9%),  which  consisted  of
lood (n  =  14,  70%)  and  tissue  (n  =  6,  30%).  Among
he 30  isolates  from  sterile  sites,  the  associated
nfections observed  included  sepsis  found  in  the
lood samples  of  8  patients  (26.7%),  followed  by
neumonia  (n  = 4,  13.3%),  tissue  abscess,  meningitis
n = 3,  10%  each),  and  tuberculosis  (n  =  1,  3.3%).  In
ddition,  4  samples  (13.3%)  were  of  unidentiﬁable
nknown condition.  Meanwhile,  of  the  isolates  from
on-sterile  samples,  the  majority  (n  =  27,  90%)  were
ssociated  with  vaginal  and  placental  infections,
ollowed by  urinary  tract  infections  (n  =  2,  6.7%)  and
issue abscess  (n  =  1,  3.3%).  Diabetes  mellitus  was
he only  underlying  condition  present  in  the  iso-
ates (n  =  7,  23.3%)  from  sterile  sites,  and  the  rest
f the  isolates  were  from  patients  immunocompro-
ised due  to  medications.  Fifty-six  patients  (93.3%)
ere of  the  Malay  and  Indian  ethnic  groups,  and  the
emaining  patients  were  Chinese  and  Punjabi  (n  =  2,
.3% for  each  ethnic  group).
ntimicrobial susceptibility testing
isc  diffusion  tests  showed  that  almost  all  of  the
solates  were  sensitive  to  penicillin  (n  =  59,  98%)
ith only  one  isolate  recorded  as  having  inter-
ediate resistance  to  penicillin  (isolate  B14  14).
n the  other  hand,  most  of  the  isolates  were
esistant to  tetracycline  (n  =  54,  90%).  Erythromy-
in resistance  was  identiﬁed  in  13  isolates  (22%),
hereas seven  isolates  (12%)  showed  resistance
o clindamycin.  There  was  only  one  isolate  from
he 15  isolates  that  was  resistant  (intermediate)
o erythromycin  and  also  showed  inducible  clin-
amycin  resistance  in  the  D  test.  No  signiﬁcant
V  (n  =  5)  3  (24)  2  (29)
% is indicated in (brackets).
* Indicate a signiﬁcant association (p < 0.05).
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Table  4  Distribution  of  serotypes  in  relation  to  ster-
ile  and  non-sterile  isolation  sites  of  the  GBS  isolates.
Serotype  Sterile  n  =  30  Non-sterile  n  =  30
Ia  (n  =  27)  12  (41)  15  (53)
II  (n  =  3)  0  (0)  3  (11)
III  (n  =  10) 7  (24) 3  (11)
V  (n  =  9) 4  (14) 5  (18)
VI  (n  =  8) 6  (21) 2  (7)
See Table 1 for specimen from sterile and non-sterile isolation
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Cluster C  is  more  common  with  non-sterile  iso-sites.
% is indicated in (brackets).
erythromycin  (p  <  0.05)  and  clindamycin  (p  <  0.01).
No signiﬁcant  association  is  observed  for  serotypes
Ia and  V  with  antibiotic  resistance  in  GBS  (to  eryth-
romycin  and  clindamycin)  (p  >  0.05).
The association  of  serotypes  according  to  isola-
tion sites  is illustrated  in  Table  4. Serotype  VII  and
VIII were  detected  in  a  limited  number  of  isolates
and were  thus  excluded.  No  signiﬁcant  association
was found  between  serotypes  and  isolation  sites  in
the present  study  (p  > 0.05).
RAPD analysisComposite  analysis  of  the  dendrogrammatic  DNA
proﬁles  generated  by  the  two  primers  was  used  in
this study  (Fig.  1).  The  analysis  showed  that  the
l
(
a
Table  5  Distribution  of  isolation  site,  hospital,  antimicrobia
to  RAPD  dendrogram  clusters.
Cluster
A  (n  =  3)  B  
Isolation  site
Sterile  (n  =  30)  3  (10)  4  
Non  sterile  (n  =  30)  —  —  
Hospital
H.  Serdang  (n  =  20)  —  —  
UKMMC  (n  =  20)  1  (5)  3  
HKL  (n  =  20)  2  (10)  1  
Resistance  isolates
Erythromycin  (n  =  13)  3  (23)*** —  
Clindamycin  (n  =  7)  2  (28.6)** —  
Serotype
Ia  (n  =  27)  2  (7.4)  3  
II  (n  =  3)  —  —  
III  (n  =  10)  1  (10)  —  
V  (n  =  9)  —  —  
VI  (n  =  8)  —  1  
% is indicated in (brackets).
* p < 0.05.
** p < 0.01.
*** p < 0.005.M.E.S.  Suhaimi  et  al.
solates  are  genetically  diverse.  Looking  at  the
verall pattern,  isolates  were  grouped  in  four  major
lusters,  named  cluster  A,  B,  C  and  D  at  only  31%
imilarity.  At  37%  similarity,  cluster  A  was  further
ivided  into  sub-cluster  A1  and  A2,  cluster  C  was
urther  clustered  in  three  sub-clusters  named  C1,
2 and  C3  and  cluster  D  was  further  divided  into
ub-clusters D1  and  D2.  Interestingly,  isolates  were
ositioned closely  according  to  their  isolation  sites
nd the  hospital’s  location.  The  majority  of  the  iso-
ates from  Hospital  Serdang  were  positioned  closely
n cluster  D,  whereas  most  of  the  isolates  from
KMMC were  positioned  closely  in  cluster  B  and
rom HKL  in  cluster  C.  Most  of  the  sterile  iso-
ates were  positioned  closely  in  cluster  A,  B  and
, whereas  many  of  non-sterile  isolates  were  pos-
tioned closely  in  cluster  C.
The distribution  of  isolates  according  to  their
espective  RAPD  dendrogram  cluster  in  relation  to
heir isolation  site,  hospital,  resistance  isolates
nd serotype  are  illustrated  in  Table  5. Cluster
 is  mainly  associated  with  GBS  isolates  resis-
ant to  erythromycin  (p  <  0.005)  and  clindamycin
p <  0.01),  while  cluster  B  is  frequently  dis-
ributed with  isolates  from  invasive  sites  (p  <  0.05).ates compared  with  isolates  from  sterile  sites
p <  0.005),  and  this  cluster  is  also  frequently  associ-
ted with  isolates  from  HKL  (p  < 0.05)  and  serotype
l  resistance  and  serotype  of  the  GBS  isolates  in  relation
(n  =  4)  C  (n  =  38)  D  (n  =  15)
(13)* 8  (27)  15  (50)***
30  (100)*** —
10  (50)  10  (50)***
(15)  11  (55)  5  (25)
(5)  17  (85)* —
8  (62)  2  (15)
3  (42.8)  2  (28.6)
(11.1)  19  (70.4)  3  (11.1)*
3  (100)
6  (60)  3  (30)
6  (67)  3  (33)
(12.5)  2  (25)* 5  (62.5)***
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Figure  1  RAPD  dendrogram  of  the  GBS  isolates  based  on  composite  analysis  in  correlation  with  the  hospital  location,
type  of  sources,  age  of  patient,  serotype  and  antimicrobial  susceptibility;  E,  Erythromycin;  CC,  Clindamycin;  TE,
Tetracycline;  C,  Chloramphenicol  and  P,  Penicillin.  S,  Susceptible;  I,  Intermediate  and  R,  Resistant.  A:  Hospital  Serdang,
B:  UKMMC,  C:  HKL.
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VI  (p  <  0.05).  Cluster  D  also  showed  a  signiﬁcance
distribution  of  sterile  isolates  (p  < 0.005),  and  this
cluster is  also  commonly  distributed  with  iso-
lates from  Hospital  Serdang  (p  < 0.005),  serotype  Ia
(p < 0.05)  and  serotype  VI  (p  <  0.005).
Discussion
The  results  of  the  antimicrobial  susceptibility  tests
suggest that  penicillin  may  still  be  a  drug  of  choice
for treating  GBS  due  to  its  use  as  an  intrapartum
antibiotic prophylactic,  although  one  high  vaginal
swab isolate  from  UKMMC  (B14  14)  showed  interme-
diate resistance  to  penicillin.  Although  no  isolates
were  recorded  as  resistant  to  penicillin  in  this
study, cases  of  reduced  susceptibility  to  penicillin
have been  reported  elsewhere  in  various  regions  in
the world.  Thus,  the  implementation  of  network
national surveillance  should  be  held  to  monitor
the emergence  of  penicillin  resistance  among  GBS
isolates [12—14].  On  the  other  hand,  the  resis-
tance rates  toward  erythromycin  and  clindamycin
were higher  in  isolates  from  sterile  sites  compared
with those  from  non-sterile  sites.  Nevertheless,  sta-
tistical analysis  showed  no  signiﬁcant  difference
for resistant  rates  against  erythromycin  and  clin-
damycin  in  those  from  non-sterile  sites  (p  >  0.05).
Molecular  approaches,  such  as  multiplex  PCR,
allow  some  non-typeable  GBS  isolates  to  be  suc-
cessfully  serotyped  by  identifying  surface  proteins
[1,15—17].  A  high  occurrence  of  serotype  Ia  in  this
study is consistent  with  another  local  study  [18]
that  reported  that  Ia  was  the  common  serotype
comprising 22.2%  among  45  isolates.  Generally,
serotype Ia,  III  and  V  are  commonly  present  in
pregnant women  and  neonates,  while  type  V  was
the common  serotype  among  non-pregnant  adults
[19].  There  is  also  a  high  occurrence  of  serotype
III, as  well  as  V,  in  cases  of  resistance  to  erythro-
mycin and  clindamycin.  This  potential  association
involving serotype  III  and  V  is of  concern  as  the
two serotypes  are  usually  associated  with  invasive
strains  [20].
In  another  study  in  Germany,  the  most  preva-
lent serotype  among  the  identiﬁed  erythromycin-
resistant isolates  was  serotype  V  (37%),  followed  by
III (27%)  [21].  In  Korea,  the  most  common  serotype
among erythromycin  (lincosamide)-resistant  iso-
lates was  also  from  serotype  V  (76%)  [22].
RAPD analysis  revealed  that  the  isolates  from
a similar  hospital  and  similar  isolation  sites  are
more related  in  their  genetic  lineage  as  reﬂected
in the  dendrogrammatic  clustering  of  the  isolates.
To a  certain  extent,  there  may  be  an  associa-
tion between  serotype  and  antimicrobial  activities
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n  some  of  the  genetic  clusters,  but  most  of  the
espective isolates  were  distantly  clustered,  sug-
esting a long  lineage  of  common  origin.  Overall,
his preliminary  study  suggests  that  the  occurrence
f genetically  distinct  GBS  in  this  local  setting
ith serotype  Ia  is  the  most  common  regardless
f the  isolation  site  and  location,  whereas  most
f erythromycin-  and  clindamycin-resistant  isolates
re signiﬁcantly  distributed  among  serotype  III.
onclusion
n  short,  MS  is  a  promising  approach  in  deter-
ining serotypes.  This  preliminary  study  suggests
hat serotype  III  was  signiﬁcantly  more  common  in
solates that  were  resistant  to  erythromycin  and
lindamycin,  although  serotype  Ia  was  the  most
ommon  among  all  of  the  GBS  isolates  regardless
f the  isolation  site  and  location.  The  isolates  were
argely distinct,  but  RAPD  analysis  segregated  the
BS isolates  according  to  geographical  area  and
solation  sites.  This  may  imply  that  isolates  col-
ected from  different  hospitals  could  have  their
wn respective  genetic  lineage  and  are  possibly
enetically adapted,  either  with  colonizing  or  inva-
ive capabilities.  Studies  involving  more  isolates  are
ecessary to  conﬁrm  the  observed  phenotypic  and
olecular  features.
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